Skip to main content
. 2023 Feb 2;29(6):781–788. doi: 10.1016/j.cmi.2023.01.019

Fig. 2.

Fig. 2

Cumulative incidence function of primary and secondary endpoints.

(A) COVID-19, (B) documented asymptomatic SARS-CoV-2 infection, (C) mild-moderate SARS-CoV-2 infection, (D) COVID-19-related hospitalization, (E) clinically relevant RTI, and (F) clinically relevant RTI excluding COVID-19.